sur Wellgistics Health, Inc. (NASDAQ:WGRX)
Wellgistics Health Ends Equity Line of Credit to Focus on Growth
Wellgistics Health, Inc., a leader in pharmaceutical distribution, has announced the termination of its equity purchase agreement with Hudson Global Ventures, LLC. This strategic shift aligns with the company's focus on accretive financing to enhance long-term shareholder value.
The company has experienced significant success in expanding its independent pharmacy network and advancing its AI-powered prescription technology. Wellgistics aims to bypass traditional PBM barriers, increase manufacturer margins, and improve patient access through this move.
According to CFO Mark DiSiena, ending the ELOC supports a disciplined capital approach, optimizing funding to align with strategic goals. CEO Brian Norton emphasizes that this decision is part of a broader strategy focused on operational strength and market capability.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Wellgistics Health, Inc.